PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,968,196 | -1.8% | 2,029,835 | +24.7% | 0.00% | 0.0% |
| Q2 2023 | $21,343,146 | -0.8% | 1,628,005 | -15.4% | 0.00% | +100.0% |
| Q1 2023 | $21,521,456 | +7137.3% | 1,924,996 | +5357.1% | 0.00% | – |
| Q4 2022 | $297,368 | -57.2% | 35,275 | -15.5% | 0.00% | – |
| Q3 2022 | $695,000 | +14.7% | 41,741 | +1.4% | 0.00% | – |
| Q2 2022 | $606,000 | -41.1% | 41,177 | -0.7% | 0.00% | – |
| Q1 2022 | $1,029,000 | -93.3% | 41,458 | -91.4% | 0.00% | -100.0% |
| Q4 2021 | $15,435,000 | -11.5% | 481,254 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $17,442,000 | +40.4% | 484,785 | +72.2% | 0.00% | 0.0% |
| Q2 2021 | $12,423,000 | -43.4% | 281,568 | -41.3% | 0.00% | -50.0% |
| Q1 2021 | $21,948,000 | -44.7% | 479,860 | -16.5% | 0.00% | -50.0% |
| Q4 2020 | $39,684,000 | – | 574,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |